Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Mar. 31, 2018	Mar. 31, 2017	Mar. 31, 2018	Mar. 31, 2017
Revenue	$ 1,012,075	$ 24,001	$ 1,086,468	$ 75,087
Operating expenses:
Selling, general, and administrative expenses	422,513	629,582	1,215,696	1,829,327
Research and development	110,900	120,753	350,549	371,667
Total operating expenses	(533,413)	(750,335)	(1,566,245)	(2,200,994)
Fair value gain (loss) on derivative financial liabilities	(608,201)	(4,995)	(1,113,147)	29,143
Fair value gain (loss) on warrant liability	(98,993)	16,400	(256,002)	54,700
(Loss) gain on extinguishment of debt	(165,985)	(42,580)	42,056	(76,486)
Gain on extinguishment of liabilities			408,009
Other income	60	364	79	473
Interest expense	(286,677)	(433,801)	(1,204,452)	(534,821)
Net Loss	$ (681,134)	$ (1,190,946)	$ (2,603,234)	$ (2,652,898)
Net loss per share – basic and diluted (in dollars per share)	$ 0	$ (0.01)	$ (0.01)	$ (0.02)
Weighted average number of common shares outstanding (in shares)	222,879,831	138,081,400	216,357,085	141,333,616